Fusion Pharmaceuticals Inc (FUSN)
21.42
-0.01
(-0.05%)
USD |
NASDAQ |
May 01, 16:00
21.42
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 34.63M |
June 30, 2023 | 34.49M |
March 31, 2023 | 34.36M |
December 31, 2022 | 34.23M |
September 30, 2022 | 34.11M |
Date | Value |
---|---|
June 30, 2022 | 9.629M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
34.63M
Maximum
Sep 2023
18.15M
Average
21.87M
Median
Total Long Term Debt (Quarterly) Benchmarks
AstraZeneca PLC | 33.31B |
Landos Biopharma Inc | -- |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 0.00 |
Edesa Biotech Inc | -- |